SummaryThe supplier operates in Class I, II, and III medical-device sales and research and development, subject to required regulatory approvals. It reports ISO9001:2015 and CE certifications, documented corrective-action and complaint-handling procedures, in-stock capacity, and stated peak/off-peak lead times. Its capabilities include OEM services for well-known brands, product R&D with documented design and validation records, and use of Catai and Solidworks. However, no SDK is available, there is no overseas warehouse, showroom, agent, or branch, and no valid manufacturing-capacity contract with related subcontractors is reported. Financial evidence is insufficient because only years are provided, not financial results or ratios.
Supplier typeThe supplier’s stated business scope covers sales and R&D of Class I, II, and III medical devices, with legally required projects subject to approval by relevant departments. This identifies it as a medical-device supplier with both commercial and development activities.
CertificationsThe supplier reports an ISO9001:2015 management-system certificate and CE product-compliance certification. These are explicit certifications relevant to quality management and product compliance.
After-Sales capabilityThe supplier has documented and followed procedures for corrective and preventive actions, customer complaints, and supplier-service assessment, plus in-stock capability and stated lead times. However, it reports no overseas warehouse, showroom, agent, branch, or overseas service countries, indicating documented service processes but limited overseas infrastructure.
R&D capabilityThe supplier states that study and innovation are company values, reports R&D responsibilities covering new-product development and technical support, maintains design input/output, review, verification, and validation records, and uses Catai and Solidworks. Its lack of an available SDK limits evidence of software-integration capability, but the documented product-development infrastructure supports an overall positive assessment.
Production capacityThe supplier reports quality assurance in quality-control processes, in-stock service capacity, written procedures with followed records, and stated lead times of within 15 workdays off-season and one month during peak season. However, it also reports no valid contract between the factory and related subcontractors, which is a specific weakness in manufacturing-capacity governance.
Customization capabilityThe supplier explicitly provides OEM services for well-known brands and has R&D personnel responsible for developing new products and supporting production, purchasing, and quality functions. R&D documentation and Catai/Solidworks capability further support product-development customization.